The Recall Desk
ModerateFDA (Drugs)·D-0690-2021·Announced 2021-07-28

Erythromycin Topical Gel 2% Recalled Due to Failed Impurity Specifications

Teligent Pharma, Inc. is recalling Erythromycin Topical Gel 2% due to failed impurities and degradation specifications. The recall affects approximately 22,824 tubes distributed nationwide.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is an FDA Class III recall for a manufacturing/specification defect with no reported illnesses or injuries mentioned in the source. Per the rubric, FDA Class III recalls are typically scored 1 or 2; the specification failure (impurities and degradation) represents a quality control issue warranting a Moderate score rather than Low.

Plain-English summary

Teligent Pharma, Inc. is recalling Erythromycin Topical Gel 2% in 30 g and 60 g tubes due to failed impurities and degradation specifications.

The affected products are: - Erythromycin Topical Gel 2%, 30 g (NDC 52565-033-30), Lot 14010, Exp July 2021 - Erythromycin Topical Gel 2%, 60 g (NDC 52565-033-60), Lot 13865, Exp June 2021 and Lot 14011, Exp July 2021

Approximately 22,824 tubes have been distributed nationwide. The product is manufactured by Teligent Pharma, Inc. in Buena, NJ.

Consumers should discontinue use of the recalled product. Healthcare providers and patients with questions should contact their healthcare provider or pharmacist for guidance.

The recalled product

Product
Erythromycin Topical Gel, 2%, Net Wt. (a) 30 g,(NDC 52565-033-30) (b) 60 g,(NDC 52565-033-60) Rx Only, Manufactured by: Teligent Pharma, Inc. , Buena, NJ 08310,
Manufacturer
Teligent Pharma, Inc.
Category
Drug — Topical Antibiotic
Hazard
Affected units
22,824

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (6)

  • 1) NDC 52565-033-30 Lot 14010
  • Exp July 2021
  • 2) NDC 52565-033-60 Lot 13865
  • Exp June 2021
  • Lot 14011
  • Exp July 2021.

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 2 recalled by Teligent Pharma, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 2 products in this recall →

Related recalls

Same manufacturer · Teligent Pharma, Inc.

See all →